C-Bridge Capital Leads Series B Round In Chinese Pharmaceutical Firm Nuance Biotech
June 28, 2018 — 09:58 CST
This Data Is Locked!
This area is available only to Subscribers.
Nuance Biotech, a China-based specialty pharmaceutical company, today announced series B fundraising of US$20 million with additional capital US$15 million tied to its acquisition of... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals